Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026)
Northwest Biotherapeutics' (NWBO) quarterly Revenue came in at $494000.0 in Q1 2026, up 31.73% year-on-year from $375000.0 in Q1 2025, and down 26.49% quarter-over-quarter from $672000.0 in Q4 2025.
Northwest Biotherapeutics (NWBO) Revenue (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' Revenue history runs 17 years deep, the most recent figure standing at $494000.0 for Q1 2026.
- On a quarterly basis, Revenue rose 31.73% year-over-year to $494000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 1.63% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, changed 0.29% from the prior year.
- Revenue retreated to $494000.0 in Q1 2026 per NWBO's latest filing, from $672000.0 in the prior quarter.
- Across five years, Revenue topped out at $880000.0 in Q1 2023 and bottomed at $131000.0 in Q2 2025.
- The 5-year median for Revenue is $403000.0 (2022), against an average of $404058.8.
- Biggest YoY gain for Revenue was 190.91% in 2025; the steepest drop was 74.31% in 2025.
- Year by year, Revenue stood at $597000.0 in 2022, then slipped by 25.46% to $445000.0 in 2023, then sank by 48.09% to $231000.0 in 2024, then soared by 190.91% to $672000.0 in 2025, then slipped by 26.49% to $494000.0 in 2026.
- Per Business Quant, the three latest NWBO Revenue figures stand at $494000.0 (Q1 2026), $672000.0 (Q4 2025), and $200000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Northwest Biotherapeutics | 271.01 Mn | 269.22 Mn | - | 494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 672,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 375,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 357,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 445,000.00 |
| Sep 30, 2023 | 406,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 880,000.00 |
| Dec 31, 2022 | 597,000.00 |
| Sep 30, 2022 | 206,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Sep 30, 2021 | 350,000.00 |
| Jun 30, 2021 | 416,000.00 |
| Mar 31, 2021 | 239,000.00 |